FDA’s QS Requirements Raise Little Industry Concern on Burden

Devices & Diagnostics Letter
A A
At the close of a comment period on the quality management systems reporting burden for devicemakers, the FDA received just one reply requesting a few clarifications.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00